Collegium Pharmaceutical Inc (NAS:COLL)
$ 30.71 -0.48 (-1.54%) Market Cap: 990.40 Mil Enterprise Value: 1.74 Bil PE Ratio: 13.18 PB Ratio: 4.22 GF Score: 80/100

Q2 2024 Collegium Pharmaceutical Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: $35.32 (+1.93%)
Operator

Greetings, and welcome to the Collegium Pharmaceutical second quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note that this conference call is being recorded.

I'll now turn the call over to Christopher James, Vice President of Investor Relations at Collegium. Thank you. You may begin

Christopher James
Collegium Pharmaceutical, Inc. - Vice President of Investor Relations

Welcome to Collegium Pharmaceutical's second quarter 2024 earnings conference call. I'm joined today by Mike Heffernan, our Interim President and Chief Executive Officer, Founder and Chairman; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.

Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional, and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot